Results 111 to 120 of about 4,852 (207)

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. [PDF]

Clin Infect Dis, 2023
Waalewijn H, Szubert AJ, Wasmann RE, Wiesner L, Chabala C, Bwakura-Dangarembizi M, Makumbi S, Nangiya J, Mumbiro V, Mulenga V, Musiime V, Monkiewicz LN, Griffiths AL, Bamford A, Doerholt K, Denti P, Burger DM, Gibb DM, McIlleron HM, Colbers A, Children with HIV in Africa – Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens (CHAPAS-4) Trial Team.   +20 more
europepmc   +1 more source

Application of UV Spectrophotometric Methods for Simultaneous Estimation of Emtricitabine and Tenofovir Alafenamide Fumarate in Bulk

, 2018
Ashwini Shelke, Madhavi Shinde, Rajendra Mogal, Rahul R. Sable, Anil G. Jadhav   +4 more
openalex   +1 more source

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis. [PDF]

BMC Gastroenterol, 2023
Liu Z, Zhao Z, Ma X, Liu S, Xin Y.
europepmc   +1 more source

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques. [PDF]

EBioMedicine, 2022
Makarova N, Singletary T, Peet MM, Mitchell J, Holder A, Dinh C, Agrahari V, Mendoza M, Pan Y, Heneine W, Clark MR, García-Lerma JG, Smith JM, Doncel GF.   +13 more
europepmc   +1 more source

405 – Efficacy and Safety Results 48 Weeks After Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) Vs Continued Tdf Treatment in Virologically-Suppressed Patients with Chronic Hepatitis B (CHB)

, 2019
Pietro Lampertico, Marı́a Buti, Scott Fung, Sang Hoon Ahn, Wan‐Long Chuang, Won Young Tak, Alnoor Ramji, Chi-Yi Chen, Edward Tam, Ho Bae, Xiaoli Ma, John F. Flaherty, Anuj Gaggar, Audrey Lau, Becket Feierbach, George Y. Wu, Vithika Suri, Mani Subramanian, Huy N. Trinh, Seung-Kew Yoon, Kosh Agarwal, Young‐Suk Lim, Henry L. Chan   +22 more
openalex   +1 more source

Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide‐based ART

, 2021
Hideaki Okochi, Alexander Louie, Nhi Phung, Kevin Zhang, Regina Tallerico, Karen Kuncze, Matthew A. Spinelli, Catherine A. Koss, Leslie Z. Benet, Monica Gandhi   +9 more
openalex   +2 more sources

Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate: Systematic Review and Meta-Analysis [PDF]

International Journal of Pulmonary & Respiratory Sciences, 2018
openaire   +1 more source

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

Neurol Neuroimmunol Neuroinflamm
Torkildsen Ø, Bru ANS, Behzadi GIN, Myhr KM.   +3 more
europepmc   +1 more source

Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus. [PDF]

Biochem Pharmacol, 2022
Liu W, Yu S, Yan B.
europepmc   +1 more source

Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/immunosuppressive therapy. [PDF]

Hepatol Forum
Dilber F, Durak S, Unsal Y, Demir M, Yildirim AE, Ellik ZM, Mehdiyev S, Adanir H, Yapali S, Demirtas CO, Ucbilek E, Balaban Y, Ekmen N, Gokcan H, Koc ES, Dincer D, Sezgin O, Simsek H, Tozun N, Arslan M, Idilman R, Etik DO, Gokcen P, Ari D, Ozdil K, Akdogan M, Boyacioglu S.   +26 more
europepmc   +1 more source